CL
BNR

CRCM LP’s Burning Rock Biotech BNR Stock Holding History

CRCM LP’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.6M Sell
282,097
-209,329
-43% -$5.48M 3.26% 4
2025
Q4 		$9.9M Buy
491,426
+269,851
+122% +$3.94M 3.35% 7
2025
Q3 		$1.92M Buy
221,575
+26,809
+14% +$192K 0.55% 10
2025
Q2 		$615K Sell
194,766
-31,524
-14% -$97.8K 0.18% 9
2025
Q1 		$1.02M Sell
226,290
-99,679
-31% -$622K 0.42% 5
2024
Q4 		$2.2M Buy
+325,969
New +$1.5M 0.89% 5

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RWMG
Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

CRCM LP's BNR Position: Q1 2026 in Review

CRCM LP reduced its Burning Rock Biotech (BNR) stake by 43% in Q1 2026, selling an estimated $5.48M and leaving 282,097 shares worth $4.6M. The position accounts for 3.26% of the portfolio, ranked #4.

CRCM LP first reported a position in BNR in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.9M in Q4 2025. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.

  • CRCM LP held 282,097 shares of Burning Rock Biotech worth $4.6M as of Q1 2026.
  • CRCM LP sold 209,329 Burning Rock Biotech shares in Q1 2026, an estimated $5.48M.
  • Burning Rock Biotech made up 3.26% of CRCM LP's portfolio in Q1 2026, its #4 holding.
  • CRCM LP first reported a position in Burning Rock Biotech in Q4 2024 and has held it in 6 quarters since.
  • CRCM LP's Burning Rock Biotech position peaked at $9.9M in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.

Based on CRCM LP's 13F filing for Q1 2026, filed 13 May 2026.